Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT04220671

Enrolling by invitation

Measles Vaccination at Health System Contacts

Mortality | Measles Vaccine | Hospital Admission | Non-specific (Heterologous) Effects of Vaccines
NCT06325657

Completed

A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants (MORISOT)

Respiratory Syncytial Virus
NCT04210375

Completed

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

Heart Failure With Reduced Ejection Fraction
NCT06429137

Completed

A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

Healthy
NCT03982199

Terminated

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older (CYPRESS)

Respiratory Tract Diseases | Respiratory Syncytial Viruses
NCT05019456

Active, not recruiting

Exercise and COVID-19 Viral T-cell Immunity (VIC)

Influenza | COVID-19 Respiratory Infection
NCT05549479

Completed

Virtual Peer-support Exercise Intervention for Older Adults with Cancer

Cancer | Aging
NCT04354480

Completed

A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older

Healthy
NCT04750577

Completed

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

Diabetic Nephropathies
NCT00767897

Completed

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

Chronic Kidney Disease | Dialysis
NCT04774887

Completed

ERADICATING CERVICAL CANCER IN KENYA (MISP2)

HIV Infections | Human Papilloma Virus
NCT06222996

Enrolling by invitation

VACCINE HESITATION

VACCINE HESITATION
NCT05371080

Active, not recruiting

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Herpes Zoster
NCT04786444

Completed

Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults

Chikungunya Virus Infection
NCT04622592

Completed

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older

Influenza
NCT02740790

Completed

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Human Papillomavirus
NCT04566276

Completed

ChulaCov19 Vaccine in Healthy Adults

COVID-19 Vaccine | Safety Issues
NCT04186000

Completed

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola (EBOVAC3DRC)

Ebola Virus Disease
NCT05083065

Completed

Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine (MECOVAC-1)

COVID-19 | Menstrual Irregularity | Vaccine | Menopausal Bleeding
NCT01197625

Active, not recruiting

Vaccine Therapy in Curative Resected Prostate Cancer Patients

Prostate Cancer
NCT04751682

Completed

Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19

SARS-CoV Infection
NCT04839315

Terminated

COVID-19 Vaccination in Rheumatic Disease Patients

Osteoarthritis | Systemic Lupus Erythematosus | Psoriatic Arthritis | Sjogren's Syndrome | Gout | Ankylosing Spondylitis | Inflammatory Myositis | Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)
NCT03391232

Completed

PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO) (OBERTO)

Colorectal Cancer
NCT02482532

Completed

Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma (MARVSmALo)

Melanoma
NCT04824651

Active, not recruiting

Covid-19 Vaccine Cohort in Specific Populations (COV-POPART)

Immune Deficiency
NCT02547428

Completed

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
NCT00000667

Completed

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

HIV Infections
NCT00492947

Withdrawn

Dendritic Cell Vaccine for Head and Neck Cancer (Dendritic)

Squamous Cell Carcinoma of Head and Neck
NCT02026089

Withdrawn

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

Persistence of Varicella Immunity
NCT04391088

Completed

Vaccination Coverage in People Linving With Diabetes (VacDiab)

Diabetes
NCT02993965

Completed

State Immunization Information Systems to Improve HPV Vaccination Rates

HPV Vaccine | Adolescent Health | Vaccine | Immunization | Reproductive Health | Preventive Health Services | Human Papiloma Virus Vaccine | Health Registry
NCT02451514

Completed

A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)

Meningococcal Disease | Infections, Meningococcal
NCT01934140

Completed

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Infections, Meningococcal
NCT02097277

Completed

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Diabetes Mellitus Type 2
NCT01962207

Completed

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

Infections, Meningococcal
NCT03392207

Completed

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (FLU-06-IB)

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Physiological Effects of Drugs | Vaccines
NCT03519568

Unknown

Clinical Study on Combined Immune Effect of EV71 Inactivated Vaccine

Enterovirus 71 Inactivated Vaccine | HFMD
NCT01960088

Completed

Adolescent Vaccination in Pharmacies (AVIP)

Evaluating Attitudes Toward HPV Vaccinations in Pharmacies | Evaluating the Provision of HPV Vaccines in a Pharmacy
NCT02253407

Completed

Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

Immune Response to MMR Vaccine
NCT03201978

Withdrawn

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Psoriasis
NCT03219203

Unknown

Immunologic Response of Hepatitis B Vaccine

Hepatitis B
NCT00303225

Withdrawn

SIGA-246 to Treat Smallpox

Vaccinia
NCT00148928

Completed

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Neoplasms, Prostate
NCT00956449

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Influenza | Seasonal Influenza
NCT02118792

Completed

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Dermatitis, Atopic
NCT00735410

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza, Vaccine
NCT00519064

Completed

Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

Influenza Disease
NCT00329576

Completed

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Hepatitis B
NCT01772901

Completed

Brief Influenza Vaccine Education to Pregnant Women

Pregnancy | Infectious Disease | Influenza
NCT01352793

Completed

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Meningitis, Meningococcal

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations